NEVRO CORP. Deferred Tax Assets, Net of Valuation Allowance
NEVRO CORP. had Deferred Tax Assets, Net of Valuation Allowance of $11.97 million as of 2024-12-31, per its 10-K filed 2025-03-04.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2025-03-04
- 2024-12-31: Deferred Tax Assets, Net of Valuation Allowance $11.97M.
- 2023-12-31: Deferred Tax Assets, Net of Valuation Allowance $9.76M.
- 2022-12-31: Deferred Tax Assets, Net of Valuation Allowance $3.94M.
- 2021-12-31: Deferred Tax Assets, Net of Valuation Allowance $4.99M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance | Deferred Tax Assets, Net of Valuation Allowance as first filed |
|---|---|---|
| 2024-12-31 | $11.97M 10-K · filed 2025-03-04 | |
| 2023-12-31 | $9.76M 10-K · filed 2025-03-04 | |
| 2022-12-31 | $3.94M 10-K · filed 2024-02-23 | |
| 2021-12-31 | $4.99M 10-K · filed 2023-02-21 | |
| 2020-12-31 | $5.50M 10-K · filed 2022-02-23 | |
| 2019-12-31 | $6.36M 10-K · filed 2021-02-24 | $1.06M 10-K · filed 2020-02-25 |
| 2018-12-31 | $929.00K 10-K · filed 2020-02-25 | |
| 2015-12-31 | $0.00 10-K · filed 2017-02-23 | |
| 2014-12-31 | $0.00 10-K · filed 2016-02-29 | |
| 2013-12-31 | $0.00 10-K · filed 2016-02-29 | |
| 2012-12-31 | $0.00 10-K · filed 2015-03-18 |